Dr. Allison Walsh Kurian, MD is a Internal Medicine Physician - Hematology practicing in Palo Alto, CA
She has not yet shared a personalized biography with Doctor.com.
University | Degree | Focus | Graduated |
---|---|---|---|
Harvard Medical School, Boston, Massachusetts | Medical Degree | 1999 |
Institution | Focus | Year |
---|---|---|
Residency - Massachusetts General Hospital | 2002 | |
Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 2005 | |
Fellowship - Stanford University School of Medicine CA | 2005 | |
Internship - Massachusetts General Hospital | 2000 | |
Internship - Massachusetts General Hospital MA | 2000 | |
Internship - Ma Gen Hospital | 2000 |
Certification | Cert. Body | Year |
---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
Position | Organization | Time |
---|---|---|
Assistant Professor of Medicine | Stanford University Medical Center | Present |
Member | Scientific Program Committee, Cancer Prevention and Epidemiology | Present |
Member | American Society of Clinical Oncology | 2011 - 2014 |
Member | Scientific Program Committee, Genetic and Molecular Epidemiology | Present |
Member | Program Committee, Professional Development | Present |
Member | American Society of Clinical Oncology | 2008 - 2011 |
Member | Career Development Subcommittee, American Society of Clinical Oncology | 2008 - 2011 |
Member | American Society of Clinical Oncology | 2012 - 2015 |
Member | American Association for Cancer Research | 2011 - 2012 |
Member | Track Leader, Cancer Prevention and Epidemiology, Scientific Program Committee | Present |
Member | American Society of Clinical Oncology | 2013 - 2014 |
Member | Oncology Consultant, Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling | Present |
Member | National Cancer Institute | 2014 - 2014 |
Member | Scientific Program Committee, Quality Care Symposium | Present |
Director | Cancer Education Seminar, Stanford Division of Oncology | 2013 - 2014 |
Member | Panel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive | 2013 - 2014 |
Member | Advisory Committee, California HealthCare Foundation | 2012 - 2014 |
Member | Board of Directors, Santa Clara County, American Cancer Society | 2011 - 2014 |
Member | Panel on Clinical Guidelines Development for Genetic/ Familial Risk: Breast and Ovarian Cancer | 2009 - 2014 |
Associate Director | Stanford Clinical Cancer Genetics Program | 2007 - 2014 |
Associate Member | Canary Center at Stanford for Cancer Early Detection | 2014 - 2014 |
Distinction | Institution | Year |
---|---|---|
California Breast Cancer Research Program | Translational Research Award | 2010 |
Robert Wood Johnson Foundation | Physician Faculty Scholars Award | 2008 |
American Society of Clinical Oncology | Young Investigator Award | 2005 |
Cancer Research and Prevention Foundation | Fellowship Award | 2005 |
California Breast Cancer Research Program | Fellowship Award | 2005 |
American Society of Clinical Oncology | Merit Award | 2004 |
California Breast Cancer Research Program | Cornelius L. Hopper Research Abstract Award | 2007 |
National Institutes of Health | BIRCWH K12 Scholar Award | 2006 |
Top 12 publications funded by the Epidemiology and Genomics Research | 2011 | |
Stanford University Cancer Institute | Suzanne Pride Bryan Award for Breast Cancer Research | 2013 |
Stanford University Cancer Institute | New Clinical Investigator Award | 2011 |
Stanford University Cancer Institute | Jan Weimer Faculty Chair for Breast Oncology | 2008 |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | Jourl of clinical oncology : official jourl of the American Society of | Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. | |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers | 2012 |
Other Publication | AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium | Oncoshare: lessons learned from building an integrated multi | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations | 2011 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Survival Alysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers | 2010 |
Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Second Primary Breast Cancer Occurrence According to Hormone Receptor Status | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Performance of BRCA1/2 mutation prediction models in Asian Americans | 2008 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | A cost-effectiveness alysis of adjuvant trastuzumab regimens in early HER2 | 2007 |
Other Publication | JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION | Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonce imaging | 2006 |
Other Publication | AMERICAN JOURL OF EPIDEMIOLOGY | Obesity and Mortality After Breast Cancer by Race | 2014 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | A young woman with bilateral breast cancer | 2013 |
Other Publication | JOURL OF ONCOLOGY PRACTICE | Information technology interventions to improve cancer care | 2013 |
Other Publication | JOURL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY | A Population-Based Observatiol Study of First | 2013 |
Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover | 2012 |
Other Publication | PLOS ONE | Single Cell Profiling of Circulating Tumor Cells | 2012 |
Other Publication | WORLD JOURL OF SURGERY | Accuracy of BRCA1/2 Mutation Prediction Models | 2012 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | In reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations | 2012 |
Other Publication | ANLS OF SURGICAL ONCOLOGY | A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer | 2011 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | High-resolution melting alysis for rapid screening of BRCA2 founder mutations in Southern Chinese | 2010 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | Genetic/familial high-risk assessment: breast and ovarian. | 2010 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California | 2010 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al | 2009 |
Other Publication | CURRENT ONCOLOGY REPORTS | The Decline in Breast Cancer Incidence: Real or Imagiry? | 2009 |
Other Publication | BREAST JOURL | Magnetic resonce galactography | 2008 |
Other Publication | ANLS OF SURGERY | CDH1 truncating mutations in the E-cadherin gene | 2007 |
Other Publication | BREAST JOURL | Ductal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage | 2007 |
Other Publication | CANCER | Breast magnetic resonce image screening | 2004 |
Other Publication | Cancer | Breast cancer treatment across health care systems | 2014 |
Other Publication | Journal of clinical oncology : official journal of the American Societ | Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. | |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California | 2013 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers | 2012 |
Other Publication | AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium | Oncoshare: lessons learned from building an integrated multi | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations | 2011 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers | 2010 |
Other Publication | BREAST CANCER RESEARCH | Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups | 2010 |
Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Second Primary Breast Cancer Occurrence According to Hormone Receptor Status | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Performance of BRCA1/2 mutation prediction models in Asian Americans | 2008 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2 | 2007 |
Other Publication | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging | 2006 |
Other Publication | GYNECOLOGIC ONCOLOGY | Histologic types of epithelial ovarian cancer: have they different risk factors? | 2005 |
Other Publication | AMERICAN JOURNAL OF EPIDEMIOLOGY | Obesity and Mortality After Breast Cancer by Race | 2014 |
Other Publication | Radiology | Response. | 2014 |
Other Publication | CANCER CAUSES & CONTROL | The California Breast Cancer Survivorship Consortium (CBCSC) | 2013 |
Other Publication | Journal of the National Comprehensive Cancer Network | A young woman with bilateral breast cancer | 2013 |
Other Publication | FAMILIAL CANCER | Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers | 2013 |
Other Publication | RADIOLOGY | The California Breast Density Information Group | |
Other Publication | JOURNAL OF ONCOLOGY PRACTICE | Information technology interventions to improve cancer care | 2013 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk | 2013 |
Other Publication | BREAST CANCER RESEARCH | Impact of breast cancer subtypes on three-year survival among adolescent and young adult women | 2013 |
Other Publication | JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY | A Population-Based Observational Study of First | 2013 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients | 2012 |
Other Publication | PLOS ONE | Identification of BRCA1 | 2012 |
Other Publication | FAMILIAL CANCER | Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations | 2012 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | A Simulation Model to Predict the Impact of Prophylactic Surgery | 2012 |
Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Age-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover | 2012 |
Other Publication | PLOS ONE | Single Cell Profiling of Circulating Tumor Cells | 2012 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early | 2012 |
Other Publication | WORLD JOURNAL OF SURGERY | Accuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in | 2012 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | In reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations | 2012 |
Other Publication | CURRENT BREAST CANCER REPORTS | Genetic Polymorphisms as Predictors of Breast Cancer Risk | 2012 |
Other Publication | BREAST CANCER RESEARCH | Occurrence of breast cancer subtypes in adolescent and young adult women | 2012 |
Other Publication | ANNALS OF SURGICAL ONCOLOGY | A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer | 2011 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry | 2011 |
Other Publication | CONTEMPORARY OBSTETRICS AND GYNECOLOGY | Hereditary cancer: counseling women at risk | 2011 |
Other Publication | BREAST CANCER RESEARCH AND TREATMENT | High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese | 2010 |
Other Publication | Journal of the National Comprehensive Cancer Network | Genetic/familial high-risk assessment: breast and ovarian. | 2010 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Increasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California | 2010 |
Other Publication | CURRENT OPINION IN OBSTETRICS & GYNECOLOGY | BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications | 2010 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Performance of Prediction Models for BRCA Mutation Carriage in Three Racial | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | In reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al | 2009 |
Other Publication | CURRENT ONCOLOGY REPORTS | The Decline in Breast Cancer Incidence: Real or Imaginary? | 2009 |
Other Publication | Current breast cancer reports | Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease. | 2009 |
Other Publication | FAMILIAL CANCER | Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers | 2008 |
Other Publication | BREAST JOURNAL | Magnetic resonance galactography | 2008 |
Other Publication | CANCER GENETICS AND CYTOGENETICS | A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature | 2007 |
Other Publication | ANNALS OF SURGERY | CDH1 truncating mutations in the E-cadherin gene | 2007 |
Other Publication | BREAST JOURNAL | Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage | 2007 |
Other Publication | APPLIED PHYSICS LETTERS | Biomedical terahertz imaging with a quantum cascade laser | 2006 |
Other Publication | HEALTH EXPECTATIONS | Opinions of women with high inherited breast cancer risk about prophylactic mastectomy | 2005 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Ductal lavage of fluid-yielding and non | 2005 |
Other Publication | CANCER | Breast magnetic resonance image screening | 2004 |
Years In Practice: 19 (started in 2006)
Accepts New Patients: Yes
Dr. Allison Walsh Kurian, MD has not yet listed the medications that she commonly prescribes.